In vitro diagnostic medical devices
Your Path to IVDR Compliance
With the implementation of EU Regulation 2017/746 on in vitro diagnostic medical devices (IVDR), you as a manufacturer face new regulatory challenges. Particularly in the areas of performance evaluation and clinical performance studies, the requirements under the IVDR have significantly increased. The IVDR also places a stronger focus on post-market surveillance (PMS) to ensure continuous monitoring of safety and performance after market release.
novineon CRO offers customized, evidence-based solutions to meet the regulatory requirements for your product and accompanies you on your path to the CE mark and beyond.
We support you in: